$12.05
0.65.24%
At close: -
$12.20
0.151.24%
After Hours: Oct 22, 9:29 AM EDT
Finch Therapeutics Gr reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Finch Therapeutics Gr using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-23 | $-16.80 | $-10.20 | -64.7 % |
Sep 2022 | 2022-11-10 | $-13.50 | $-12.00 | -12.5 % |
Dec 2021 | 2022-03-31 | $-12.00 | $-9.60 | -25.0 % |
Sep 2021 | 2021-11-10 | $-6.30 | $-12.60 | 50.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-23 | $8.00K | $400.00K | -98.0 % |
Sep 2022 | 2022-11-10 | $138.00K | $750.00K | -81.6 % |
Finch Therapeutics Gr (FNCH) is scheduled to report earnings on December 6, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-3.01, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.